Medovate, in collaboration with anaesthetists in the UK NHS, has developed the SAFIRA system to revolutionize standard regional anaesthesia practice and enhance patient safety. By eliminating the need for a second person and incorporating a unique safety feature, the SAFIRA system offers anaesthetists full control and reduces the risk of nerve damage during injections. We delve into the partnership between Medovate and Fannin Limited, which allows anaesthetists across the Island of Ireland to access and apply this award-winning technology in their everyday practice, resulting in improved patient care and outcomes.
Enhancing Regional Anaesthesia Practice with Safira System
Understand how the innovative Safira system is revolutionizing regional anaesthesia practice with enhanced efficiency and safety.
Regional anaesthesia plays a critical role in numbing specific areas of the body for surgical procedures while allowing patients to stay awake. Traditionally, this has been a two-person procedure, but the Safira system developed by Medovate changes the game. By empowering anaesthetists with complete control without the need for an assistant, the Safira system transforms regional anaesthesia practice into a more efficient and effective one-person procedure.
What sets the Safira system apart is its built-in safety feature that automatically stops injection at a calibrated threshold. This significantly reduces the risk of nerve damage from high-pressure injections, ultimately enhancing patient safety during regional anaesthesia procedures.
The Impact of the Safira System on Anaesthetists
Learn about the benefits that the Safira system offers to anaesthetists in terms of convenience and procedural control.
The Safira system empowers anaesthetists by streamlining the regional anaesthesia procedure. With the elimination of the need for a second person, anaesthetists can independently carry out procedures, leading to enhanced convenience and improved efficiency.
Additionally, the Safira system's unique safety feature provides anaesthetists with an added layer of control and peace of mind. With automatic injection stoppage at a calibrated threshold, it minimizes the chances of nerve damage and ensures patient safety.
Fannin Limited: Distributor of the Safira System in Ireland
Explore the partnership between Medovate and Fannin Limited in making the Safira system accessible to anaesthetists across the Island of Ireland.
Fannin Limited, renowned for its commitment to innovative healthcare solutions, has been appointed as the exclusive distributor of the Safira system in Ireland. With their expertise and dedication to providing high-quality medical products, Fannin Limited serves as the ideal partner for expanding the availability of the Safira system.
Anaesthetists across the Island of Ireland can now access and apply the award-winning Safira system in their practice. This partnership between Medovate and Fannin Limited ensures that the clinically proven benefits of the Safira system, including improved patient safety and enhanced procedural efficiency, can be experienced throughout the region.
International Success and Recognitions
Discover the worldwide reach of the Safira system and its recognition as a groundbreaking technological innovation for patient safety.
Beyond the shores of Ireland, the Safira system has achieved significant success and recognition across international markets. The innovative technological solution has been successfully launched in the UK, the United States, Australia and New Zealand, Singapore, and the Middle East, demonstrating its effectiveness and impact worldwide.
Furthermore, the Safira system was awarded the prestigious Health Services Journal (HSJ) award for “Patient Safety Innovation of the Year 2021”. This notable accolade recognizes the system's unique contributions to patient safety in the field of regional anaesthesia.
With this global success and recognition, anaesthetists worldwide can trust and adopt the Safira system, further propelling its positive impact on patient care and safety.
Conclusion
The Safira system developed by Medovate is revolutionizing regional anaesthesia practice by providing anaesthetists with enhanced control, efficiency, and safety. Through its one-person procedure and unique built-in safety feature, the Safira system enables anaesthetists to deliver improved patient outcomes. The partnership between Medovate and Fannin Limited ensures that this award-winning technology is accessible to anaesthetists across the Island of Ireland, further advancing the field of regional anaesthesia.
